Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1988 Nov;34:2489–2498.

Allogeneic and Autologous Bone-Marrow Transplantation

H Joachim Deeg
PMCID: PMC2218992  PMID: 21253121

Abstract

The author of this paper presents an overview of the current status of bone marrow transplantation, including indications, pre-transplant considerations, the transplant procedure, acute and delayed transplant-related problems, results currently attainable, and a short discussion of possible future developments.

Keywords: bone-marrow transplantation

Full text

PDF
2489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anasetti C., Doney K. C., Storb R., Meyers J. D., Farewell V. T., Buckner C. D., Appelbaum F. R., Sullivan K. M., Clift R. A., Deeg H. J. Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. Ann Intern Med. 1986 Apr;104(4):461–466. doi: 10.7326/0003-4819-104-4-461. [DOI] [PubMed] [Google Scholar]
  2. Appelbaum F. R., Storb R., Ramberg R. E., Shulman H. M., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Sanders J., Self S. Treatment of preleukemic syndromes with marrow transplantation. Blood. 1987 Jan;69(1):92–96. [PubMed] [Google Scholar]
  3. Appelbaum F. R., Sullivan K. M., Buckner C. D., Clift R. A., Deeg H. J., Fefer A., Hill R., Mortimer J., Neiman P. E., Sanders J. E. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol. 1987 Sep;5(9):1340–1347. doi: 10.1200/JCO.1987.5.9.1340. [DOI] [PubMed] [Google Scholar]
  4. Arfors K. E., Lundberg C., Lindbom L., Lundberg K., Beatty P. G., Harlan J. M. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood. 1987 Jan;69(1):338–340. [PubMed] [Google Scholar]
  5. Atkinson K., Biggs J., Cooley M., Farrelly H., O'Flaherty E., Raphael H., Ashby M., Concannon A., Dodds A., Morgan G. A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy. Aust N Z J Med. 1987 Feb;17(1):16–23. doi: 10.1111/j.1445-5994.1987.tb05043.x. [DOI] [PubMed] [Google Scholar]
  6. Barlogie B., Alexanian R., Dicke K. A., Zagars G., Spitzer G., Jagannath S., Horwitz L. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood. 1987 Sep;70(3):869–872. [PubMed] [Google Scholar]
  7. Barrett A., Depledge M. H., Powles R. L. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int J Radiat Oncol Biol Phys. 1983 Jul;9(7):1029–1033. doi: 10.1016/0360-3016(83)90393-0. [DOI] [PubMed] [Google Scholar]
  8. Beatty P. G., Clift R. A., Mickelson E. M., Nisperos B. B., Flournoy N., Martin P. J., Sanders J. E., Stewart P., Buckner C. D., Storb R. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med. 1985 Sep 26;313(13):765–771. doi: 10.1056/NEJM198509263131301. [DOI] [PubMed] [Google Scholar]
  9. Beatty P. G., Dahlberg S., Mickelson E. M., Nisperos B., Opelz G., Martin P. J., Hansen J. A. Probability of finding HLA-matched unrelated marrow donors. Transplantation. 1988 Apr;45(4):714–718. doi: 10.1097/00007890-198804000-00010. [DOI] [PubMed] [Google Scholar]
  10. Belmont J. W., Henkel-Tigges J., Chang S. M., Wager-Smith K., Kellems R. E., Dick J. E., Magli M. C., Phillips R. A., Bernstein A., Caskey C. T. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer. Nature. 1986 Jul 24;322(6077):385–387. doi: 10.1038/322385a0. [DOI] [PubMed] [Google Scholar]
  11. Blume K. G., Beutler E., Bross K. J., Chillar R. K., Ellington O. B., Fahey J. L., Farbstein M. J., Forman S. J., Schmidt G. M., Scott E. P. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med. 1980 May 8;302(19):1041–1046. doi: 10.1056/NEJM198005083021901. [DOI] [PubMed] [Google Scholar]
  12. Blume K. G., Forman S. J., Snyder D. S., Nademanee A. P., O'Donnell M. R., Fahey J. L., Krance R. A., Sniecinski I. J., Stock A. D., Findley D. O. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation. 1987 Mar;43(3):389–392. doi: 10.1097/00007890-198703000-00014. [DOI] [PubMed] [Google Scholar]
  13. Bowden R. A., Sayers M., Flournoy N., Newton B., Banaji M., Thomas E. D., Meyers J. D. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med. 1986 Apr 17;314(16):1006–1010. doi: 10.1056/NEJM198604173141602. [DOI] [PubMed] [Google Scholar]
  14. Cameron B. F., Smith D. B., Cody B. Government regulations and sickle cell trait. Blood. 1983 Jun;61(6):1279–1280. [PubMed] [Google Scholar]
  15. Champlin R. E., Gale R. P. The early complications of bone marrow transplantation. Semin Hematol. 1984 Apr;21(2):101–108. [PubMed] [Google Scholar]
  16. Deeg H. J., Sanders J., Martin P., Fefer A., Neiman P., Singer J., Storb R., Thomas E. D. Secondary malignancies after marrow transplantation. Exp Hematol. 1984 Sep;12(8):660–666. [PubMed] [Google Scholar]
  17. Deeg H. J., Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med. 1984;35:11–24. doi: 10.1146/annurev.me.35.020184.000303. [DOI] [PubMed] [Google Scholar]
  18. Deeg H. J., Storb R., Thomas E. D. Bone marrow transplantation: a review of delayed complications. Br J Haematol. 1984 Jun;57(2):185–208. [PubMed] [Google Scholar]
  19. Deeg H. J., Storb R., Weiden P. L., Shulman H. M., Graham T. C., Torok-Storb B. J., Thomas E. D. Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. Blood. 1979 Apr;53(4):552–557. [PubMed] [Google Scholar]
  20. Dinsmore R., Kirkpatrick D., Flomenberg N., Gulati S., Kapoor N., Shank B., Reid A., Groshen S., O'Reilly R. J. Allogeneic bone marrow transplantation for patients with acute lymphoblastic leukemia. Blood. 1983 Aug;62(2):381–388. [PubMed] [Google Scholar]
  21. Filipovich A. H., Vallera D. A., Youle R. J., Haake R., Blazar B. R., Arthur D., Neville D. M., Jr, Ramsay N. K., McGlave P., Kersey J. H. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow. Transplantation. 1987 Jul;44(1):62–69. doi: 10.1097/00007890-198707000-00015. [DOI] [PubMed] [Google Scholar]
  22. Gale R. P. Potential utilization of a national HLA-typed donor pool for bone marrow transplantation. Transplantation. 1986 Jul;42(1):54–58. doi: 10.1097/00007890-198607000-00011. [DOI] [PubMed] [Google Scholar]
  23. Gingrich R. D., Ginder G. D., Goeken N. E., Howe C. W., Wen B. C., Hussey D. H., Fyfe M. A. Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood. 1988 May;71(5):1375–1381. [PubMed] [Google Scholar]
  24. Glazier A., Tutschka P. J., Farmer E. R., Santos G. W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983 Jul 1;158(1):1–8. doi: 10.1084/jem.158.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Goldman J. M., Apperley J. F., Jones L., Marcus R., Goolden A. W., Batchelor R., Hale G., Waldmann H., Reid C. D., Hows J. Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med. 1986 Jan 23;314(4):202–207. doi: 10.1056/NEJM198601233140403. [DOI] [PubMed] [Google Scholar]
  26. Goldman J. M., Gale R. P., Horowitz M. M., Biggs J. C., Champlin R. E., Gluckman E., Hoffmann R. G., Jacobsen S. J., Marmont A. M., McGlave P. B. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med. 1988 Jun;108(6):806–814. doi: 10.7326/0003-4819-108-6-806. [DOI] [PubMed] [Google Scholar]
  27. Hansen J. A., Clift R. A., Thomas E. D., Buckner C. D., Storb R., Giblett E. R. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med. 1980 Sep 4;303(10):565–567. doi: 10.1056/NEJM198009043031007. [DOI] [PubMed] [Google Scholar]
  28. Herzig R. H., Bortin M. M., Barrett A. J., Blume K. G., Gluckman E., Horowitz M. M., Jacobsen S. J., Marmont A., Masaoka T., Prentice H. G. Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission. Lancet. 1987 Apr 4;1(8536):786–789. doi: 10.1016/s0140-6736(87)92809-1. [DOI] [PubMed] [Google Scholar]
  29. Hood A. F., Vogelsang G. B., Black L. P., Farmer E. R., Santos G. W. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol. 1987 Jun;123(6):745–750. doi: 10.1001/archderm.123.6.745. [DOI] [PubMed] [Google Scholar]
  30. Kernan N. A., Flomenberg N., Dupont B., O'Reilly R. J. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation. 1987 Jun;43(6):842–847. [PubMed] [Google Scholar]
  31. Klingemann H. G., Storb R., Fefer A., Deeg H. J., Appelbaum F. R., Buckner C. D., Cheever M. A., Greenberg P. D., Stewart P. S., Sullivan K. M. Bone marrow transplantation in patients aged 45 years and older. Blood. 1986 Mar;67(3):770–776. [PubMed] [Google Scholar]
  32. Korngold R., Sprent J. T cell subsets and graft-versus-host disease. Transplantation. 1987 Sep;44(3):335–339. doi: 10.1097/00007890-198709000-00002. [DOI] [PubMed] [Google Scholar]
  33. Lum L. G. The kinetics of immune reconstitution after human marrow transplantation. Blood. 1987 Feb;69(2):369–380. [PubMed] [Google Scholar]
  34. Maraninchi D., Abecasis M., Gastaut J. A., Herve P., Sebahoun G., Flesch M., Blanc A. P., Carcassonne Y. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors. Cancer Treat Rep. 1984 Mar;68(3):471–474. [PubMed] [Google Scholar]
  35. Martin P. J., Hansen J. A., Buckner C. D., Sanders J. E., Deeg H. J., Stewart P., Appelbaum F. R., Clift R., Fefer A., Witherspoon R. P. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood. 1985 Sep;66(3):664–672. [PubMed] [Google Scholar]
  36. McDonald G. B., Sharma P., Matthews D. E., Shulman H. M., Thomas E. D. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984 Jan-Feb;4(1):116–122. doi: 10.1002/hep.1840040121. [DOI] [PubMed] [Google Scholar]
  37. McGlave P. B., Arthur D. C., Weisdorf D., Kim T., Goldman A., Hurd D. D., Ramsay N. K., Kersey J. H. Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemia. Blood. 1984 Jan;63(1):219–222. [PubMed] [Google Scholar]
  38. O'Reilly R. J., Brochstein J., Dinsmore R., Kirkpatrick D. Marrow transplantation for congenital disorders. Semin Hematol. 1984 Jul;21(3):188–221. [PubMed] [Google Scholar]
  39. Philip T., Armitage J. O., Spitzer G., Chauvin F., Jagannath S., Cahn J. Y., Colombat P., Goldstone A. H., Gorin N. C., Flesh M. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med. 1987 Jun 11;316(24):1493–1498. doi: 10.1056/NEJM198706113162401. [DOI] [PubMed] [Google Scholar]
  40. Reisner Y., Kapoor N., Kirkpatrick D., Pollack M. S., Cunningham-Rundles S., Dupont B., Hodes M. Z., Good R. A., O'Reilly R. J. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood. 1983 Feb;61(2):341–348. [PubMed] [Google Scholar]
  41. Sanders J. E., Buckner C. D., Leonard J. M., Sullivan K. M., Witherspoon R. P., Deeg H. J., Storb R., Thomas E. D. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation. 1983 Sep;36(3):252–255. doi: 10.1097/00007890-198309000-00005. [DOI] [PubMed] [Google Scholar]
  42. Sanders J. E., Pritchard S., Mahoney P., Amos D., Buckner C. D., Witherspoon R. P., Deeg H. J., Doney K. C., Sullivan K. M., Appelbaum F. R. Growth and development following marrow transplantation for leukemia. Blood. 1986 Nov;68(5):1129–1135. [PubMed] [Google Scholar]
  43. Santos G. W., Hess A. D., Vogelsang G. B. Graft-versus-host reactions and disease. Immunol Rev. 1985 Dec;88:169–192. doi: 10.1111/j.1600-065x.1985.tb01158.x. [DOI] [PubMed] [Google Scholar]
  44. Storb R., Prentice R. L., Buckner C. D., Clift R. A., Appelbaum F., Deeg J., Doney K., Hansen J. A., Mason M., Sanders J. E. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med. 1983 Feb 10;308(6):302–307. doi: 10.1056/NEJM198302103080602. [DOI] [PubMed] [Google Scholar]
  45. Storb R., Thomas E. D. Allogeneic bone-marrow transplantation. Immunol Rev. 1983;71:77–102. doi: 10.1111/j.1600-065x.1983.tb01069.x. [DOI] [PubMed] [Google Scholar]
  46. Storb R., Thomas E. D., Buckner C. D., Appelbaum F. R., Clift R. A., Deeg H. J., Doney K., Hansen J. A., Prentice R. L., Sanders J. E. Marrow transplantation for aplastic anemia. Semin Hematol. 1984 Jan;21(1):27–35. [PubMed] [Google Scholar]
  47. Storb R., Weiden P. L., Sullivan K. M., Appelbaum F. R., Beatty P., Buckner C. D., Clift R. A., Doney K. C., Hansen J., Martin P. J. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood. 1987 Jul;70(1):116–121. [PubMed] [Google Scholar]
  48. Sullivan K. M., Shulman H. M., Storb R., Weiden P. L., Witherspoon R. P., McDonald G. B., Schubert M. M., Atkinson K., Thomas E. D. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981 Feb;57(2):267–276. [PubMed] [Google Scholar]
  49. Sullivan K. M., Witherspoon R. P., Storb R., Deeg H. J., Dahlberg S., Sanders J. E., Appelbaum F. R., Doney K. C., Weiden P., Anasetti C. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood. 1988 Aug;72(2):555–561. [PubMed] [Google Scholar]
  50. Takvorian T., Canellos G. P., Ritz J., Freedman A. S., Anderson K. C., Mauch P., Tarbell N., Coral F., Daley H., Yeap B. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. N Engl J Med. 1987 Jun 11;316(24):1499–1505. doi: 10.1056/NEJM198706113162402. [DOI] [PubMed] [Google Scholar]
  51. Thomas E. D., Buckner C. D., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Sale G. E., Sanders J. E., Singer J. W., Shulman H. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med. 1979 Sep 13;301(11):597–599. doi: 10.1056/NEJM197909133011109. [DOI] [PubMed] [Google Scholar]
  52. Thomas E. D., Clift R. A., Fefer A., Appelbaum F. R., Beatty P., Bensinger W. I., Buckner C. D., Cheever M. A., Deeg H. J., Doney K. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med. 1986 Feb;104(2):155–163. doi: 10.7326/0003-4819-104-2-155. [DOI] [PubMed] [Google Scholar]
  53. Thomas E. D., Storb R. Technique for human marrow grafting. Blood. 1970 Oct;36(4):507–515. [PubMed] [Google Scholar]
  54. Touraine J. L. Bone-marrow and fetal-liver transplantation in immunodeficiencies and inborn errors of metabolism: lack of significant restriction of T-cell function in long-term chimeras despite HLA-mismatch. Immunol Rev. 1983;71:103–121. doi: 10.1111/j.1600-065x.1983.tb01070.x. [DOI] [PubMed] [Google Scholar]
  55. Tura S., Cavo M., Baccarani M., Ricci P., Gobbi M. Bone marrow transplantation in multiple myeloma. Scand J Haematol. 1986 Feb;36(2):176–179. doi: 10.1111/j.1600-0609.1986.tb00824.x. [DOI] [PubMed] [Google Scholar]
  56. Tutschka P. J., Copelan E. A., Klein J. P. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood. 1987 Nov;70(5):1382–1388. [PubMed] [Google Scholar]
  57. Weiden P. L., Sullivan K. M., Flournoy N., Storb R., Thomas E. D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 1981 Jun 18;304(25):1529–1533. doi: 10.1056/NEJM198106183042507. [DOI] [PubMed] [Google Scholar]
  58. Weiner R. S., Bortin M. M., Gale R. P., Gluckman E., Kay H. E., Kolb H. J., Hartz A. J., Rimm A. A. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med. 1986 Feb;104(2):168–175. doi: 10.7326/0003-4819-104-2-168. [DOI] [PubMed] [Google Scholar]
  59. Yeager A. M., Kaizer H., Santos G. W., Saral R., Colvin O. M., Stuart R. K., Braine H. G., Burke P. J., Ambinder R. F., Burns W. H. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med. 1986 Jul 17;315(3):141–147. doi: 10.1056/NEJM198607173150301. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES